Anticancer plant-derivatives: deciphering their oncopreventive and therapeutic potential in molecular terms

• Published in: Future journal of pharmaceutical sciences Vol. 9; no. 1; pp. 14 - 30
• Main Authors: Gahtori, Rekha, Tripathi, Ankita H., Kumari, Amrita, Negi, Nidhi, Paliwal, Ashutosh, Tripathi, Prabhanshu, Joshi, Penny, Rai, Ramesh C., Upadhyay, Santosh K.
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01-12-2023; Springer Nature B.V; SpringerOpen
• Subjects: Anticancer; Asthma; Ayurvedic medicine; Cancer therapies; Chemo-prevention; Chemotherapy; Disease; Drug-resistance; Drugs; Epithelial to mesenchymal transition; Flavonoids; Herbal medicine; Knowledge; Medical prognosis; Medicine; Medicine & Public Health; Metabolites; Metastasis; Pharmaceutical sciences; Phenols; Phytochemicals; Phytomedicine; Review; Testicular cancer; United States > US; India; Epithelial to mesenchymal transition; Chemo-prevention; Metastasis; Drug-resistance; Anticancer; Phytomedicine
• ISSN: 2314-7253; 2314-7245; 2314-7253
• DOI: 10.1186/s43094-023-00465-5

Background
Over the years, phytomedicines have been widely used as natural modalities for the treatment and prevention of various diseases by different ethnic groups across the globe. Although, 25% of drugs in the USA contain at least one plant-derived therapeutic compound, currently there is a paucity of plant-derived active medicinal ingredients in the pharmaceutical industry. Scientific evidence-based translation of plant-derived ethnomedicines for their clinical application is an urgent need. The anticancer and associated properties (antioxidative, anti-inflammatory, pro-apoptotic and epithelial-mesenchymal transition (EMT) inhibition) of various plant extracts and phytochemicals have been elucidated earlier. Several of the plant derivatives are already in use under prophylactic/therapeutic settings against cancer and many are being investigated under different phases of clinical trials.
Main body
The purpose of this study is to systematically comprehend the progress made in the area of prophylactic and therapeutic potential of the anticancerous plant derivatives. Besides, we aim to understand their anticancer potential in terms of specific sub-phenomena, such as anti-oxidative, anti-inflammatory, pro-apoptotic and inhibition of EMT, with an insight of the molecules/pathways associated with them. The study also provides details of classes of anticancer compounds, their plant source(s) and the molecular pathway(s) targeted by them. In addition to the antioxidative and antiproliferative potentials of anticancer plant derivatives, this study emphasizes on their EMT-inhibition potential and other ‘anticancer related’ properties. The EMT is highlighted as a phenomenon of choice for targeting cancer due to its role in the induction of metastasis and drug resistance. Different phytochemicals in pre-clinical or clinical trials, with promising chemopreventive/anticancer activities have been enlisted and the plant compounds showing synergistic anticancer activity in combination with the existing drugs have been discussed. The review also unravels the need of carrying out pan-signalome studies for identifying the cardinal pathways modulated by phytomedicine(s), as in many cases, the molecular pathway(s) has/have been randomly studied.
Conclusion
This review systematically compiles the studies regarding the impact of various plant derivatives in different cancers and oncogenic processes, as tested in diverse experimental model systems. Availability of more comprehensive information on anticancer phyto-constituents, their relative abundance in crude drugs, pathways/molecules targeted by phytomedicines, their long-term toxicity data and information regarding their safe use under the combinatorial settings, would open greater avenues of their utilization in future against this dreaded disease.
Graphical Abstract